Thermo Fisher Scientific acquired Solventum’s purification and filtration business for $4 billion. The new filtration unit will operate within Thermo Fisher’s Life Sciences Solutions segment.
The deal includes Solventum’s bioprocessing filtration, healthcare and industrial filtration, and membrane technologies, according to an Sept. 2 news release from the devicemaker. The company said the purchase strengthens its bioproduction tools and expands its presence in industries that require ultrapure water such as battery and semiconductor manufacturing.
The business is expected to generate about $750 million in revenue in 2025, the release said.
